PPM Industry Executives Present COVID-19 Strategy, Actions and Transaction Update | Virtual Conference

April 9, 2020 | Webinar

Overview

The rapid emergence of COVID-19 immediately and dramatically affected the physician practice management (PPM) industry. Executives have been under extreme pressure to develop strategies and take actions to best position their companies to handle the impact of this unprecedented occurrence. At the same time, an industry with an insatiable appetite for acquisitions has had to pause deals.

During this in-depth, virtual conference, you will hear from chief executive officers of leading PPMs about their COVID-19 strategies and the actions they are taking on behalf of their companies. You will then hear from chief development officers and physician practice investment bankers regarding current M&A activity and how they are preparing for the post-COVID-19 environment.

This program is a follow-up to our April 3, 2020 virtual conference. To access the event recording, click here.

Agenda

COVID-19 Impact on Specialties and Anticipated Road to Recovery
Speaker:

Jeff Woods, Managing Director, U.S. Healthcare Practice, EY-Parthenon

CEO Panel: The Current State and Future of the PPM Industry
In the wake of COVID-19 and its impact on the PPM industry, PPMs must act quickly while being thoughtful about the future. In this session, CEOs of leading PPMs, covering a variety of specialties, will share their strategies for dealing with and surviving COVID-19, as well as their insights regarding the PPM industry post COVID-19 and anticipated lingering effects.
Speakers:

Chad Eckes, CEO, Pinnacle Dermatology
Joseph Garcia, CEO, Gastro Health
Douglas Wisor, CEO National Spine & Pain Centers

PPM Transactions Panel: An Era of Uncertainty
COVID-19 has had a more immediate and dramatic impact on PPM transactions than the abrupt ending of the PPM industry in the 1990s. In the 1990s, the cessation of transactions was part of a collapse of essentially the entire PPM industry (other than hospital-based and dental). This time it is solely attributable to COVID-19. Regardless of the cause for uncertainty, important questions still remain– when we emerge from this crisis, will PPM transactional activity resume to pre-COVID-19 volume? Will multiples be impacted? Will financing be readily available? Will physicians have the appetite to do deals? This panel of chief development officers from leading PPMs and active physician practice investment bankers will provide their insights into these and other questions.
Speakers:

Jay Barnes, Managing Director, Greenhill & Co.
Chris Fusco, Chief Growth Officer, Orthopaedic & Neurosurgery Specialists
William D. Lautman, Managing Partner, Nexus Health Capital

Dig Deeper